You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Last Updated: September 22, 2023

Cent Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for CENT PHARMS, and what generic and branded alternatives to CENT PHARMS drugs are available?

CENT PHARMS has ten approved drugs.

Summary for Cent Pharms

US Patents:	0
Tradenames:	10
Ingredients:	6
NDAs:	10

Drugs and US Patents for Cent Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cent Pharms	SYNOPHYLATE	theophylline sodium glycinate	ELIXIR;ORAL	006333-008	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Cent Pharms	PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE	chlorpheniramine maleate; pseudoephedrine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	019428-001	Aug 2, 1988		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Cent Pharms	DEXACEN-4	dexamethasone sodium phosphate	INJECTABLE;INJECTION	084342-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Cent Pharms	THEOCLEAR-100	theophylline	TABLET;ORAL	085353-002	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Cent Pharms	THEOPHYLLINE	theophylline	CAPSULE, EXTENDED RELEASE;ORAL	088689-001	Feb 12, 1985		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Cent Pharms	PREDNISOLONE ACETATE	prednisolone acetate	INJECTABLE;INJECTION	084717-002	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson

Harvard Business School

Baxter

Dow

Medtronic

AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.